Objective: To assess mortality and risk factors associated with reexploration for hemorrhage in patients undergoing coronary artery bypass grafting (CABG).
H
EMORRHAGE necessitating reexploration after coronary artery bypass grafting (CABG) remains a frequent complication with significant adverse consequences. Reexploration for bleeding, which occurs after 2% to 6% of CABG procedures, has been associated with case-fatality rates as high as 22%. 1 Patients undergoing reexploration for bleeding also consume considerable resources, including blood products and those related to prolonged intensive care and overall hospital stays. [1] [2] [3] [4] Efforts to reduce rates of reexploration for bleeding have included use of prothrombotic agents, such as aprotinin and aminocaproic acid. However, because of their potential adverse effects and expense, these agents have generally been reserved for patients considered to be at particularly high risk for postoperative bleeding.
Because risk factors for reexploration after CABG are not well established, we performed a prospective, regional study of postoperative hemorrhage in patients undergoing coronary artery bypass in northern New England. This study was performed when aprotinin and aminocaproic acid were used very infrequently in the region.
RESULTS
Of the 8586 consecutive patients undergoing CABG between 1992 and 1995, a total of 305 (3.6%) underwent reexploration for postoperative bleeding. The in-hospital mortality rate of patients who underwent reexploration was substantially higher than that of those patients without reoperation (9.5% vs 3.3%, P<.001). Also, length of stay from operation to hospital discharge was 6 days longer on average (14.5 days vs 8.6 days, P<.001). 
PAPER

UNIVARIATE ANALYSIS
Rates of reexploration for bleeding were significantly associated with age and BSA ( Table 1) . Patients 75 years or older had reexploration rates 2.6-fold higher than did patients younger than 55 years (P<.001) (Figure, A) . Smaller patients (BSA Ͻ1.6 m 2 ) had reexploration rates 2.3-fold higher than larger patients (BSA Ն2.0 m 2 [P<.001]). Stratified by sex, there was a monotonic increase in the risk of bleeding among both men (P for trend, Ͻ.001) and women (P for trend, .06) (Figure, B) .
The risk of reexploration for hemorrhage was not associated with sex, comorbidities, prior CABG (Table  1) , or measures of cardiac disease severity ( Table 2) . The use of thrombolytics within 48 hours of the CABG was slightly associated with higher risks of reexploration, but was not statistically significant (5.0% vs 3.3%, P=.08).
Time on cardiopulmonary bypass, number of distal anastomoses, and the intraoperative insertion of an intra-aortic balloon pump were associated with higher rates of hemorrhage requiring reexploration. Patients on cardiopulmonary bypass more than 150 minutes had a 5-fold higher risk of reexploration than patients on bypass less than 60 minutes (P<.001) (Figure, C). Patients requiring 5 or more distal anastomoses had a 1.9-fold higher risk of reexploration than those requiring fewer than 3 anastomoses (P=.002) (Figure, D) . Patients requiring an IABP intraoperatively had a reexploration rate of 8.0%, as compared with 3.2% in those without an IABP (P<.001). However, preoperative IABP insertion was not a risk factor for reexploration.
MULTIVARIATE ANALYSIS
In multivariate logistic regression model, only age, BSA, cardiopulmonary bypass time, and number of distal anastomoses were found to be significantly associated with rates of reexploration for hemorrhage. The model had a moderate predictive accuracy (area under the receiver operating characteristic curve=0.66) and good calibration (Hosmer-Lemeshow goodness-of-fit 2 test=4.84, df=8, P=.77).
COMMENT
In this prospective regional study, 3.6% of patients required reexploration, an incidence rate consistent with
PATIENTS AND METHODS
SUBJECTS AND DATA COLLECTION
The Northern New England Cardiovascular Disease Study Group is a voluntary research consortium representing all 5 medical centers in Maine, New Hampshire, and Vermont where CABG surgery is performed. Since 1987, the group has maintained a prospective registry of all patients undergoing cardiac surgery in the region. This analysis was based on 8586 consecutive patients undergoing isolated CABG between January 1, 1992, and July 3, 1995. Data collection, methods and definitions, patient characteristics, and determinants of in-hospital mortality in this group of patients have been described previously in detail. 5, 6 The following data were recorded prospectively for all patients: patient age and sex, body surface area (BSA), cardiac catheterization results (degree of left main coronary artery stenosis, total number of significantly diseased vessels, left ventricular end-diastolic pressure, ejection fraction), prior CABG, priority of surgery (emergency, urgent, or elective), thrombolytic therapy within 48 hours, use of an intraaortic balloon pump (IABP), and total time of cardiopulmonary bypass. The ejection fraction results were scored using the method described by Pierpont et al. 7 The number of diseased coronary vessels was assessed using criteria established by the National Heart, Lung, and Blood Institute Coronary Artery Surgery Study. 8 The left main coronary artery was classified as diseased if any stenosis was greater than or equal to 50% of the luminal diameter. The left anterior descending, left circumflex, right coronary, or posterior descending artery were considered diseased if any stenosis was greater than or equal to 70% of the luminal diameter. In leftdominant coronary anatomy, left main coronary artery disease was equivalent to 3-vessel disease. Coronary artery bypass grafting was defined as emergent when medical factors relating to the patient's cardiac disease dictated that surgery be performed within hours to prevent morbidity or death. Urgent CABG was defined by the presence of clinical factors requiring that the patient stay in the hospital to have the operation before discharge. The remaining cases were defined as elective.
Postoperative hemorrhage was defined as bleeding that resulted in return to the operating room. The decision to reexplore was at the discretion of the individual surgeon. We did not attempt to categorize the specific indication for reoperation, such as excessive chest tube drainage, collection of blood within the chest, or cardiac tamponade. Data on those patients with high chest tube output who did not require reexploration and their outcomes were not collected. In-hospital deaths occurring during the CABG admission were recorded concurrently.
ANALYSIS
Standard statistical methods (
2 test for categorical data and t tests for continuous variables) were used to compare the characteristics of patients with and without reexploration. We used multivariate logistic regression analysis to explore the association between hemorrhage and potential risk factors and to adjust for potentially confounding variables. 9 The multivariate model was developed by incrementally testing variables found in univariate analysis to be significant at the P<.10 level. The likelihood ratio test was used to compare nested logistic regression models. The Hosmer-Lemeshow goodness-of-fit statistic was calculated. As a measure of test accuracy, the area under the receiver operating characteristic curve, a graphic representation of relation of the true-positive rate (ie, the sensitivity of the test) and the false-positive rate (ie, 1 minus the specificity of the test), was calculated. 10 Analysis was performed using STATA software (Stata Corp, College Station, Tex).
findings from other series. [1] [2] [3] Patients undergoing reexploration had significantly increased rates of in-hospital mortality (9.5% vs 3.3%) as well as prolonged hospital stays (mean, 14 days vs 8.6 days).
Risk factor analysis showed that increased age, lower BSA, prolonged cardiopulmonary bypass, and increasing number of distal anastomoses were associated with higher rates of reexploration for bleeding. Previous work by Moulton et al 2 and a prospective multivariate analysis by Despotis et al 11 also found age and time on cardiopulmonary bypass to be risk factors for reexploration. Prolonged time on bypass increases the activation of fibrinolysis and induces an inflammatory response. Active plasmin released during bypass may induce platelet activation, which leads to acquired platelet dysfunction and deleterious hemostatic changes. 12 We also identified number of distal anastomoses and BSA as risk factors for reexploration after CABG. An increased number of distal anastomoses requires greater time on cardiopulmonary bypass, increases the number of potential bleeding sites, and increases the overall complexity of the procedure. While increased bleeding risks with more distal anastomoses seem plausible on clinical grounds, the reasons why smaller patients have increased risks are unclear but may be the result of dilu- tional effects. Smaller patients have proportionally smaller circulating blood volumes and therefore decreased total amounts of coagulation factors compared with larger patients. Fluids administered intravenously and in the pump prime will more quickly dilute these factors in smaller patients, and may therefore lead more frequently to coagulopathies.
Rates of reexploration after CABG were not correlated with several variables often considered risk factors for postoperative bleeding in general. For example, recent thrombolytic therapy, urgent or emergent surgery, and prior open heart surgery were not significantly associated with reexploration for hemorrhage. Although one previous study identified chronic renal insufficiency as a risk factor for reexploration, 2 our study showed no such association between dialysis-dependent renal failure and higher rates of reexploration. While female sex has been linked with higher rates of postoperative transfusion after CABG, 13 our study showed no difference in reexploration rates among men and women (3.5% and 3.6%, respectively). Other authors have noted increased mediastinal drainage and postoperative transfusion rates in patients with an IABP.
14 While IABP was associated with reexploration risk in our univariate analysis, this association was not statistically significant in multivariate analysis.
It is important to consider this study's strengths and limitations. Given the large sample size, this study had sufficient power to detect most clinically important predictors of postoperative bleeding requiring reexploration. In addition, data were collected prospectively, limiting the potential for bias in the ascertainment of risk factor and outcome variables. Finally, because this regional study was population-based, our results should be generalizable.
Among the limitations, we did not consider all potentially important risk factors for postoperative bleeding. While we did not have sufficient data to assess the role of preoperative aspirin and heparin use, other studies have not identified these variables as risk factors for clinically important bleeding after CABG. 13, 15 Preoperative laboratory findings, including bleeding times, have also not been shown to predict reexploration rates. 2 This study focused solely on postoperative bleeding sufficient to require reexploration. Other less dramatic but clinically important indicators of postoperative bleeding, such as transfusion rates and mediastinal drainage, were not examined. Also, our analysis focused on mortality. Other studies have shown that reexploration for hemorrhage after CABG also increases rates of nonfatal adverse outcomes, including hemodialysis, atrial arrhythmias, adult respiratory distress syndrome and prolonged mechanical ventilation, and sepsis.
1,2 While these outcomes were not specifically examined, they likely are responsible for part of the increased length of stay seen in patients who underwent reexploration.
Efforts to reduce rates of reexploration for bleeding have included use of prothrombotic agents. Among the most commonly used are aprotinin and aminocaproic acid, antifibrinolytic agents that inhibit plasmin and plasmin-induced platelet dysfunction. Several studies have suggested that these agents reduce postoperative bleeding and transfusion requirements with CABG. 4, 15 However, there remains some concern about potential risks of thrombotic complications and other adverse effects with aprotinin and other antifibrinolytics. 11, 16 Moreover, because some of these agents (aprotinin in particular) are expensive, few centers are using them routinely in patients undergoing CABG. These agents were not commonly used at the time of our study, and the effects of changes in practice patterns and bleeding trends have yet to be determined.
Identifying patients at high risk for postoperative hemorrhage is important if cardiac surgeons are to adopt cost-effective strategies for bleeding prevention. Our results suggest that surgeons should have low thresholds to initiate aprotinin and aminocaproic acid therapy in patients older than 75 years, small patients, those with potentially prolonged cardiopulmonary bypass, and those requiring higher numbers of distal anastomoses. 
